BOM/544619 (BOM/544619)

Bombay Stock Exchange: BOM/544619 · INR

₹1,116

+94.15 (+9.2%)· Recorded snapshot

Market cap	126.4B
Revenue (ttm)	7.1B
Net income (ttm)	1.9B
EPS (ttm)	₹16.2
P/E (trailing)	68.8x
P/E (forward)	62.2x
Dividend	₹1.50 (0.13%)
Volume	103,210

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.1B
Net income (ttm): 1.9B
EPS (ttm): ₹16.2
P/E (trailing): 68.8x
P/E (forward): 62.2x
Market cap: 126.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E62.2

P25 n/aP50 n/aP75 n/a

Trailing P/E68.8

P25 n/aP50 n/aP75 n/a

ROE22

P25 n/aP50 n/aP75 n/a

ROIC17.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BOM/544619 indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

INR

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-10-29
Employees	525
Employees change	45
Employees growth	9.38%
Enterprise value	INR 126.9B
Exchange	Bombay Stock Exchange
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1989
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	INE0QPI01025
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Market cap	INR 126.4B
Next earnings date	2026-10-29
Price	INR 1,116.05
Price currency	INR
Sector	Healthcare
SIC code	2833
Stock price date	2026-10-28
Symbol	bom/544619
Website	https://www.sudeeppharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	1.45%
EV/Earnings	67.38x
EV/EBIT	55.24x
EV/EBITDA	51.63x
EV/Sales	17.98x
FCF / EV yield	-0.31%
FCF yield	-0.31%
Forward P/E	62.18x
Graham number	179.28927
Graham upside	-83.94%
Industry forward P/E	33.04x
Industry P/E	38.96x
P/B ratio	12.99x
P/E ratio	68.85x
P/OCF ratio	132.59x
P/S ratio	17.91x
Price / tangible book value	14.4x
Price/EBITDA ratio	51.42x
Sector forward P/E	36.13x
Sector P/E	45.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	32.55%
EBITDA margin	34.83%
Effective tax rate	24.48%
Gross margin	64.04%
Operating margin	32.55%
Pretax margin	35.39%
Profit margin	26.69%
Profit per employee	INR 3.6M
Revenue per employee	INR 13.4M
ROA	12.39%
ROCE	21.27%
ROE	22.04%
ROIC	17.94%
ROIC (5Y)	29.64%
Tax / revenue	8.67%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	29.18%
EPS growth (Q)	28.21%
EPS growth (QoQ)	-18.02%
Gross profit growth	28.4%
Gross profit growth (Q)	24.28%
Net income growth	33.68%
Net income growth (Q)	31.63%
Net income growth (QoQ)	-17.04%
OCF growth	42.74%
Operating income growth	23.07%
Operating income growth (Q)	25.32%
Revenue growth	31.84%
Revenue growth (Q)	26.7%
Revenue growth (QoQ)	-13.2%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -1.3B
Depreciation and amortization	INR 142.2M
EBIT	INR 2.3B
EBITDA	INR 2.5B
EPS	INR 16.21
Financing cash flow	INR 1B
Free cash flow	INR -388.8M
Gross profit	INR 4.5B
Income taxes	INR 611.6M
Investing cash flow	INR -2B
Net borrowing	INR 102.9M
Net cash flow	INR 18M
Net income	INR 1.9B
Operating income	INR 2.3B
Revenue	INR 7.1B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 85.40
Debt / EBITDA	0.77
Debt / equity	0.19
Interest coverage	28.76
Net cash (debt)	INR -742.9M
Net cash / market cap	-0.59%
Net debt / EBITDA	0.3
Net debt / equity	0.08
Piotroski F-Score	4
Shareholders' equity	INR 9.7B
Tangible book value	INR 8.8B
Tangible book value per share	INR 78.32
Total assets	INR 13.3B
Total cash	INR 1.2B
Total debt	INR 1.9B
Total liabilities	INR 3.6B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.61
Current ratio	2.91
Inventory turnover	1.11
Net working capital	INR 4.9B
Quick ratio	1.45
Working capital	INR 4.7B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.47%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-08-07
Dividend payment years	1
Dividend per share	INR 1.50
Dividend yield	0.13%
Ex-dividend date	2026-07-23
Last dividend	INR 1.50
Payout ratio	8.99%
Shareholder yield	-3.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	INR 883.43
1D price change	9.21%
1M price change	-12.55%
1M total return	-12.55%
1W price change	5.2%
1W total return	5.2%
20-day SMA	INR 1,070.38
200-day SMA	INR 814.87
3M price change	23.62%
3M total return	23.62%
50-day SMA	INR 1,135.68
50-day SMA vs 200-day SMA	50over200
52-week high	INR 1,376.00
52-week high date	2026-09-07
52-week low	INR 524.95
52-week low date	2026-01-21
6M price change	50.14%
6M total return	50.4%
All-time high	INR 1,376.00
All-time high date	2026-09-07
All-time low	INR 524.95
All-time low date	2026-01-21
Average true range (ATR)	INR 63.82
Average volume	22.9K
Change from 52-week high	-18.89%
Change from 52-week low	112.6%
Change from all-time high	-25.73%
Change from all-time low	94.67%
Change from open	8.14%
Day's gap	0.99%
Dollar volume	INR 115.2M
High price	INR 1,124.00
Low price	INR 1,030.70
Monthly RSI	0
Open price	INR 1,032.00
Position in 52-week range	91.48%
Previous close	INR 1,021.90
Price vs 150-day SMA	15.67%
Price vs 20-day SMA	-4.53%
Price vs 200-day SMA	25.41%
Price vs 50-day SMA	-10.02%
Relative volume	4.51
RSI	43.23
Sharpe ratio	0.82
Sortino ratio	1.44
Volume	103.2K
Weekly RSI	54.15
YTD price change	69.62%
YTD total return	69.92%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25.4M
Shares change (QoQ)	1.22%
Shares change (YoY)	3.47%
Shares held by insiders	37.13%
Shares held by institutions	14.83%

Deeper analysis on BOM/544619

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BOM/544619 report

Is a complete BOM/544619 research report available?

No complete published report is available for bom/544619 (BOM/544619) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BOM/544619 (BOM/544619)

Price

Financial snapshot

Fair-value bridge

Latest news · BOM/544619

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BOM/544619 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BOM/544619

Frequently asked questions